Vetericyn is a revolutionary wound care product based on hypochlorous acid technology that has transformed equine wound management since its introduction to the veterinary market. This FDA-cleared antimicrobial solution mimics the body's own natural immune response, utilizing the same oxidizing compounds that white blood cells produce to fight infection. Unlike traditional antiseptics that can damage healthy tissue, Vetericyn selectively targets pathogens while being completely non-toxic to healthy cells. This unique safety profile has made it one of the most trusted and widely used wound care products in equine medicine, suitable for use on all wound types without concern for tissue damage or cytotoxicity.
The active component in Vetericyn is hypochlorous acid, a naturally occurring substance produced by the body's immune cells during the inflammatory response to infection. When white blood cells encounter pathogens, they generate hypochlorous acid through an enzymatic process to kill bacteria, viruses, and fungi. Vetericyn harnesses this natural antimicrobial mechanism in a stable, pH-balanced formulation that can be applied topically to wounds. The hypochlorous acid disrupts microbial cell membranes and interferes with essential metabolic processes, providing rapid broad-spectrum antimicrobial activity against bacteria, viruses, fungi, and spores without contributing to antibiotic resistance.
Vetericyn is available in multiple formulations designed for different applications and user preferences. The spray format allows for no-touch application that is particularly useful for sensitive wounds or horses that are reluctant to be handled. The gel formulation provides longer contact time with wound surfaces and is useful for vertical wounds where liquid would run off. Specialized products within the Vetericyn line address specific needs including eye and ear care, wound and skin care, and antimicrobial hydrogels. All formulations share the same hypochlorous acid technology but are optimized for their intended applications.
The exceptional safety profile of Vetericyn sets it apart from traditional wound care products and makes it suitable for virtually any application where antimicrobial activity is desired. The product is non-toxic if ingested, non-irritating to eyes and mucous membranes, and causes no damage to healthy tissue even with repeated application. This safety allows Vetericyn to be used on all wound types, at all healing stages, and in sensitive locations where other antiseptics might be contraindicated. Horses do not need to be prevented from licking treated areas, and the product can be safely used around eyes, nose, and mouth when appropriate formulations are selected.
